Pharmaceutical industry: GSK takes over cancer specialists for more than ten billion dollars

—·1d

The British pharmaceutical giant is expanding its oncology portfolio with the takeover of the US biotech Nuvalent. It is an early success for the new CEO Miels.

TickersGSK, USChannelscurrencies, semiconductors, stocksCountriesgermany, europeCategoriesmergers-acquisitions

Open original source ↗

Published

6/9/2026, 7:12:58 AM

Fetched

6/9/2026, 9:07:29 AM

Confidence

60 / 100

Relevance

44 / 100

Trust

—

Language